Lonotropic Glutamate Receptor Antagonist - Global and China Top Players Market Share and Ranking 2023

Tables and Figures

Table 1. Lonotropic Glutamate Receptor Antagonist Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Lonotropic Glutamate Receptor Antagonist Market Restraints
Table 3. Lonotropic Glutamate Receptor Antagonist Market Trends
Table 4. Lonotropic Glutamate Receptor Antagonist Industry Policy
Table 5. Global Lonotropic Glutamate Receptor Antagonist Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Lonotropic Glutamate Receptor Antagonist Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Lonotropic Glutamate Receptor Antagonist Sales Quantity by Company, (2018-2023) & (Units), Ranked Based on Sales in 2022
Table 8. Global Lonotropic Glutamate Receptor Antagonist Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Lonotropic Glutamate Receptor Antagonist Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Lonotropic Glutamate Receptor Antagonist Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Lonotropic Glutamate Receptor Antagonist Mergers & Acquisitions, Expansion Plans
Table 12. Global Lonotropic Glutamate Receptor Antagonist Manufacturers Product Type
Table 13. Head Office and Lonotropic Glutamate Receptor Antagonist Production Site of Key Manufacturer
Table 14. Lonotropic Glutamate Receptor Antagonist Capacity of Major Manufacturers and Future Plan
Table 15. China Lonotropic Glutamate Receptor Antagonist Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Lonotropic Glutamate Receptor Antagonist Sales Quantity by Company, (2018-2023) & (Units), Ranked Based on Sales in 2022
Table 17. China Lonotropic Glutamate Receptor Antagonist Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Lonotropic Glutamate Receptor Antagonist Production & Forecast by Region, 2018 VS 2022 VS 2029, (Units)
Table 19. Global Lonotropic Glutamate Receptor Antagonist Production by Region, 2018-2023, (Units)
Table 20. Global Lonotropic Glutamate Receptor Antagonist Production Forecast by Region, 2024-2029, (Units)
Table 21. Global Key Players of Lonotropic Glutamate Receptor Antagonist Upstream (Raw Materials)
Table 22. Global Lonotropic Glutamate Receptor Antagonist Typical Customers
Table 23. Lonotropic Glutamate Receptor Antagonist Typical Distributors
Table 24. By Type, Global Lonotropic Glutamate Receptor Antagonist Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Lonotropic Glutamate Receptor Antagonist Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Lonotropic Glutamate Receptor Antagonist Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Lonotropic Glutamate Receptor Antagonist Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029, (Units)
Table 29. By Country, Global Lonotropic Glutamate Receptor Antagonist Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Lonotropic Glutamate Receptor Antagonist Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Lonotropic Glutamate Receptor Antagonist Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029, (Units)
Table 33. By Country, Global Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2018-2029
Table 34. Artemis Neuroscience Company Information, Head Office, Market Area, and Industry Position
Table 35. Artemis Neuroscience Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 36. Artemis Neuroscience Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Artemis Neuroscience Company Profile and Main Business
Table 38. Artemis Neuroscience Recent Developments
Table 39. VistaGen Therapeutics Company Information, Head Office, Market Area, and Industry Position
Table 40. VistaGen Therapeutics Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 41. VistaGen Therapeutics Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. VistaGen Therapeutics Company Profile and Main Business
Table 43. VistaGen Therapeutics Recent Developments
Table 44. Rottapharm Madaus Company Information, Head Office, Market Area, and Industry Position
Table 45. Rottapharm Madaus Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 46. Rottapharm Madaus Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Rottapharm Madaus Company Profile and Main Business
Table 48. Rottapharm Madaus Recent Developments
Table 49. Amorsa Therapeutics Company Information, Head Office, Market Area, and Industry Position
Table 50. Amorsa Therapeutics Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 51. Amorsa Therapeutics Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Amorsa Therapeutics Company Profile and Main Business
Table 53. Amorsa Therapeutics Recent Developments
Table 54. Newron Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 55. Newron Pharmaceuticals Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 56. Newron Pharmaceuticals Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Newron Pharmaceuticals Company Profile and Main Business
Table 58. Newron Pharmaceuticals Recent Developments
Table 59. Purdue Biopharma Company Information, Head Office, Market Area, and Industry Position
Table 60. Purdue Biopharma Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 61. Purdue Biopharma Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Purdue Biopharma Company Profile and Main Business
Table 63. Purdue Biopharma Recent Developments
Table 64. Relmada Therapeutics Company Information, Head Office, Market Area, and Industry Position
Table 65. Relmada Therapeutics Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 66. Relmada Therapeutics Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Relmada Therapeutics Company Profile and Main Business
Table 68. Relmada Therapeutics Recent Developments
Table 69. BioCrea GmbH Company Information, Head Office, Market Area, and Industry Position
Table 70. BioCrea GmbH Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 71. BioCrea GmbH Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. BioCrea GmbH Company Profile and Main Business
Table 73. BioCrea GmbH Recent Developments
Table 74. Cerecor Inc. Company Information, Head Office, Market Area, and Industry Position
Table 75. Cerecor Inc. Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 76. Cerecor Inc. Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Cerecor Inc. Company Profile and Main Business
Table 78. Cerecor Inc. Recent Developments
Table 79. NeurOp Inc. Company Information, Head Office, Market Area, and Industry Position
Table 80. NeurOp Inc. Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 81. NeurOp Inc. Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. NeurOp Inc. Company Profile and Main Business
Table 83. NeurOp Inc. Recent Developments
Table 84. UCB SA Company Information, Head Office, Market Area, and Industry Position
Table 85. UCB SA Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 86. UCB SA Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. UCB SA Company Profile and Main Business
Table 88. UCB SA Recent Developments
Table 89. Novartis AG Company Information, Head Office, Market Area, and Industry Position
Table 90. Novartis AG Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 91. Novartis AG Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Novartis AG Company Profile and Main Business
Table 93. Novartis AG Recent Developments
Table 94. Luc Therapeutics Inc. Company Information, Head Office, Market Area, and Industry Position
Table 95. Luc Therapeutics Inc. Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 96. Luc Therapeutics Inc. Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Luc Therapeutics Inc. Company Profile and Main Business
Table 98. Luc Therapeutics Inc. Recent Developments
Table 99. Evotec AG Company Information, Head Office, Market Area, and Industry Position
Table 100. Evotec AG Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 101. Evotec AG Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Evotec AG Company Profile and Main Business
Table 103. Evotec AG Recent Developments
List of Figures
Figure 1. Lonotropic Glutamate Receptor Antagonist Picture
Figure 2. Global Lonotropic Glutamate Receptor Antagonist Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Lonotropic Glutamate Receptor Antagonist Sales Quantity, (Units) & (2018-2029)
Figure 4. Global Lonotropic Glutamate Receptor Antagonist Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Lonotropic Glutamate Receptor Antagonist Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units) & (2018-2029)
Figure 7. China Lonotropic Glutamate Receptor Antagonist Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Lonotropic Glutamate Receptor Antagonist Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Lonotropic Glutamate Receptor Antagonist Market Share of Global, 2018-2029
Figure 10. Global Lonotropic Glutamate Receptor Antagonist Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Lonotropic Glutamate Receptor Antagonist Key Participants, Market Share, 2022
Figure 12. Global Lonotropic Glutamate Receptor Antagonist Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Lonotropic Glutamate Receptor Antagonist Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Lonotropic Glutamate Receptor Antagonist Production Market Share & Forecast by Region, 2018-2029
Figure 15. Lonotropic Glutamate Receptor Antagonist Industry Chain
Figure 16. Lonotropic Glutamate Receptor Antagonist Procurement Model
Figure 17. Lonotropic Glutamate Receptor Antagonist Sales Model
Figure 18. Lonotropic Glutamate Receptor Antagonist Sales Channels, Direct Sales, and Distribution
Figure 19. N-Methyl-D-Aspartate Receptors
Figure 20. Marine Human Alginate Receptors
Figure 21. α-Amino-3 Hydroxy-5 Methyl-4 Isoxazole Receptors
Figure 22. By Type, Global Lonotropic Glutamate Receptor Antagonist Consumption Value, 2018-2029, US$ Million
Figure 23. By Type, Global Lonotropic Glutamate Receptor Antagonist Consumption Value Market Share, 2018-2029
Figure 24. By Type, Global Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029, (Units)
Figure 25. By Type, Global Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2018-2029
Figure 26. By Type, Global Lonotropic Glutamate Receptor Antagonist Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 27. Hospitals
Figure 28. Clinics
Figure 29. Research Institutes
Figure 30. Others
Figure 31. By Application, Global Lonotropic Glutamate Receptor Antagonist Consumption Value, 2018-2029, US$ Million
Figure 32. By Application, Global Lonotropic Glutamate Receptor Antagonist Consumption Value Market Share, 2018-2029
Figure 33. By Application, Global Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029, (Units)
Figure 34. By Application, Global Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2018-2029
Figure 35. By Application, Global Lonotropic Glutamate Receptor Antagonist Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 36. By Region, Global Lonotropic Glutamate Receptor Antagonist Consumption Value Market Share, 2018-2029
Figure 37. By Region, Global Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2018-2029
Figure 38. North America Lonotropic Glutamate Receptor Antagonist Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, North America Lonotropic Glutamate Receptor Antagonist Consumption Value Market Share, 2022
Figure 40. Europe Lonotropic Glutamate Receptor Antagonist Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country, Europe Lonotropic Glutamate Receptor Antagonist Consumption Value Market Share, 2022
Figure 42. Asia Pacific Lonotropic Glutamate Receptor Antagonist Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country/Region, Asia Pacific Lonotropic Glutamate Receptor Antagonist Consumption Value Market Share, 2022
Figure 44. South America Lonotropic Glutamate Receptor Antagonist Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, South America Lonotropic Glutamate Receptor Antagonist Consumption Value Market Share, 2022
Figure 46. Middle East & Africa Lonotropic Glutamate Receptor Antagonist Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 47. U.S. Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029, (Units)
Figure 48. By Type, U.S. Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 49. By Application, U.S. Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 50. Europe Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029, (Units)
Figure 51. By Type, Europe Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, Europe Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 53. China Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029, (Units)
Figure 54. By Type, China Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, China Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 56. Japan Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029, (Units)
Figure 57. By Type, Japan Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, Japan Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 59. South Korea Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029, (Units)
Figure 60. By Type, South Korea Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 61. By Application, South Korea Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 62. Southeast Asia Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029, (Units)
Figure 63. By Type, Southeast Asia Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 64. By Application, Southeast Asia Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 65. India Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029, (Units)
Figure 66. By Type, India Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 67. By Application, India Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 68. Middle East & Africa Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029, (Units)
Figure 69. By Type, Middle East & Africa Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 70. By Application, Middle East & Africa Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 71. Research Methodology
Figure 72. Breakdown of Primary Interviews
Figure 73. Bottom-up and Top-down Approaches
Figure 74. Top-down Approaches

Reason to Buy

• Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Pharma & Healthcare Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets